These included breast cancer, where 87% of the tumors exhibited ROR2 expression, glioblastoma with over 90% ROR2-positive tumors, and n NB, where 80% of the tumors showed ROR2 presence (Kim et al., 2015). This evidence concerns the gene ROR2 and breast cancer.